Emyria Archives | Cannabiz

Zelira

Company news: Zelira Therapeutics; Creso Pharma; Emyria

by Martin Lane September 21, 2021September 21, 2021

Zelira Therapeutics Zelira Therapeutics has signed an exclusive five-year deal with German distributor Adjupharm GmbH, giving […]

Roby Zomer

Company news: MGC Pharma; Emyria; ECS Botanics; Rua Bioscience; AusCann; Cannasouth; Cronos; Althea

by Martin Lane September 2, 2021September 2, 2021

Company news: Bod; Emyria; Cann Group; Health House; Releaf Clinics; Creso Pharma; Greenfern; Medlab

by cannabiz team August 26, 2021August 26, 2021

Cann Group and Emyria go their separate ways on S3 registration

by Martin Lane August 13, 2021August 13, 2021

Company news: Emyria; Medibis; Incannex; Eqalis; Greenfern; Creso Pharma; Highlands Investments

by cannabiz team August 12, 2021August 12, 2021

josh fegan

Company news: Althea; Lifespot; Emyria; MGC Pharma; Incannex; RotoGro; Clever Leaves

by Martin Lane July 28, 2021July 29, 2021

We’re coming for you, TGA warns rule-breaking clinics after issuing 32 cease and desist orders

by Steve Jones July 15, 2021July 22, 2021

Company news: MedReleaf; Cronos Australia; MediPharm Labs; Elixinol Wellness; Lifespot Health; Emyria; Helius Therapeutics

by Martin Lane June 28, 2021July 1, 2021

Emyria files new patents for IBS treatment

by Martin Lane June 17, 2021June 17, 2021

New evidence shows opioid use and pain decline, quality of life goes up after cannabis treatment

by Martin Lane June 10, 2021June 16, 2021